Capricor Therapeutics, Inc.

CAPR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001133869

SEC filings (opens in a new tab)

No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Capricor Therapeutics, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of CAPR: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	108	1	121	+14
Shares	17.3M	169.1K	18.3M	+1.17M (+6.8%)
Value	$239.1M	$2.33M	$174.0M	−$62.8M (−26.5%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Capricor Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to CAPR in Q1 2025
Institution	Shares	Value	% of portfolio
Pier Capital, LLC	354,181	$3.36M	0.56%
Avidity Partners Management LP	239,000	$2.27M	0.47%
Jump Financial, LLC	163,021	$1.55M	0.02%
Caption Management, LLC	140,000	$1.33M	0.06%
Nuveen, LLC	89,141	$845.9K	0.00%
AWM Investment Company, Inc.	87,765	$832.9K	0.11%
Tang Capital Management LLC	79,100	$750.7K	0.04%
XTX Topco Ltd	54,870	$520.7K	0.03%
HBK Sorce Advisory LLC	49,844	$473.0K	0.01%
Verition Fund Management LLC	47,651	$452.2K	0.00%
Schonfeld Strategic Advisors LLC	34,815	$330.4K	0.00%
Franklin Resources Inc	23,332	$221.4K	0.00%
Connective Capital Management, LLC	23,128	$219.5K	0.20%
Fox Run Management, L.L.C.	22,360	$212.2K	0.03%
Acuitas Investments, LLC	21,530	$204.3K	0.17%
Quadrature Capital Ltd	18,899	$179.2K	0.00%
Worth Venture Partners, LLC	16,345	$155.1K	0.29%
Stoneridge Investment Partners LLC	15,853	$150.0K	0.13%
Creative Planning	13,286	$126.1K	0.00%
Envestnet Asset Management Inc	12,048	$114.3K	0.00%
Arizona State Retirement System	11,707	$111.1K	0.00%
Virtus Investment Advisers, Inc.	11,448	$108.6K	0.03%
Raymond James Financial Inc	11,116	$105.5K	0.00%
Virginia Retirement Systems Et Al	10,400	$98.7K	0.00%
Citizens Financial Group Inc	10,023	$95.1K	0.00%
Signaturefd, LLC	82	$778	0.00%
Jones Financial Companies LLLP	53	$610	0.00%
Lindbrook Capital, LLC	52	$493	0.00%
C M Bidwell & Associates Ltd	43	$408	0.00%
Parkside Financial Bank & Trust	40	$380	0.00%
EverSource Wealth Advisors, LLC	39	$370	0.00%
True Wealth Design, LLC	5	$48	0.00%
Bessemer Group Inc	26	$0	0.00%

Sold out (19)

Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of CAPR in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Altium Capital Management LP	714,000	$9.85M
Maven Securities LTD	150,000	$2.07M
UBS Oconnor LLC	104,798	$1.45M
Jane Street Group, LLC	103,734	$1.43M
Marshall Wace, LLP	59,303	$818.4K
ADAR1 Capital Management, LLC	56,120	$774.5K
D. E. Shaw & Co., Inc.	53,734	$741.5K
Freestone Grove Partners LP	22,920	$316.3K
Bryce Point Capital, LLC	22,709	$313.4K
Gsa Capital Partners LLP	18,243	$252.0K
AQR Capital Management LLC	11,097	$153.1K
ProShare Advisors LLC	10,317	$142.4K
Virtus ETF Advisers LLC	4,957	$68.4K
BFSG, LLC	150	$2.07K
Aster Capital Management (DIFC) Ltd	111	$1.53K
R Squared Ltd	30	$414
Northwestern Mutual Wealth Management Co	19	$262
GAMMA Investing LLC	10	$138
Lazard Asset Management LLC	69	$0

Not filed for Q1 2025 yet (1)

Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CAPR in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	169,111	$2.33M